For 12 patients with CDK12-altered prostate cancer, the median age at initial diagnosis was 67 years, the median PSA level was 18.5 ng/dL, and all patients had a Gleason grade  ≥ 4. The gene discussed is KLK3; the disease is prostate cancer.